SESSION TITLE: ECMO Posters
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 28, 2015 at 01:30 PM - 02:30 PM
PURPOSE: We studied national trends in Extracorporeal Membrane Oxygenator (ECMO) use for ARDS in the USA from 2008 to 2012.
METHODS: We performed retrospective analysis using Healthcare Cost and Utilization project-National Inpatient Sample (HCUP-NIS) hospital discharge data from 2008 to 2012. ICD-9 codes and CPT codes were used to identify patients with who were placed on ECMO for ARDS. We captured ARDS patients using the following codes: 518.82, 518.51, 518.52, 518.53, 518.81, 518.84, 518.7, 518.4, 861.20, 785.52, 995.92 and procedures codes: 96.70, 96.71, and 96.72.
RESULTS: Trend results over time show increasing use of ECMO in ARDS treatment. 135 of 158076 ARDS patients (0.08%) were treated with ECMO in 2008. The following years this number seems to have increased; 365 of 171473 (0.21%) in 2009, 270 of 183073 (0.14%) in 2010, 399 of 201195 (0.19%) in 2011 and 535 of 201095 (0.26%) in 2012. The hospital length of stay for ARDS patients treated with ECMO decreased from 39 days in 2008 to 28.5 days in 2012. Age, gender, race and socio-economic differences in ECMO use for ARDS are also being assessed and will be presented.
CONCLUSIONS: From 2008 onwards, there has been an increase in the use of ECMO as rescue therapy for ARDS in the United States.
CLINICAL IMPLICATIONS: As ECMO use in ARDS becomes prevalent, more familiarity and training of Critical Care Physicians and trainees will be required.
DISCLOSURE: The following authors have nothing to disclose: Bhupinder Natt, Hem Desai, Chithra Poongkunran, Christian Bime, Nimal Singh, Yuval Raz
No Product/Research Disclosure Information